16-68828262-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP2BA1

This summary comes from the ClinGen Evidence Repository: The NM_004360.5(CDH1):c.2253C>T (p.Asn751=) variant has an allele frequency of 0.10006 (10%, 3546/35438 alleles, 185 homozygotes) in the Latino subpopulation of the gnomAD v2.1.1 cohort (BA1; BP2). Therefore, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the CDH1 Variant Curation Expert Panel (Variant Interpretation Guidelines Version 3.1): BA1, BP2. LINK:https://erepo.genome.network/evrepo/ui/classification/CA167533/MONDO:0007648/007

Frequency

Genomes: 𝑓 0.039 ( 142 hom., cov: 32)
Exomes 𝑓: 0.033 ( 1031 hom. )

Consequence

CDH1
NM_004360.5 synonymous

Scores

2

Clinical Significance

Benign reviewed by expert panel B:17

Conservation

PhyloP100: -2.44

Publications

48 publications found
Variant links:
Genes affected
CDH1 (HGNC:1748): (cadherin 1) This gene encodes a classical cadherin of the cadherin superfamily. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate the mature glycoprotein. This calcium-dependent cell-cell adhesion protein is comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function of this gene is thought to contribute to cancer progression by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. This gene is present in a gene cluster with other members of the cadherin family on chromosome 16. [provided by RefSeq, Nov 2015]
CDH1 Gene-Disease associations (from GenCC):
  • blepharocheilodontic syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • CDH1-related diffuse gastric and lobular breast cancer syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • cleft soft palate
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • orofacial cleft 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • blepharocheilodontic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004360.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
NM_004360.5
MANE Select
c.2253C>Tp.Asn751Asn
synonymous
Exon 14 of 16NP_004351.1A0A0U2ZQU7
CDH1
NM_001317184.2
c.2070C>Tp.Asn690Asn
synonymous
Exon 13 of 15NP_001304113.1P12830-2
CDH1
NM_001317185.2
c.705C>Tp.Asn235Asn
synonymous
Exon 14 of 16NP_001304114.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH1
ENST00000261769.10
TSL:1 MANE Select
c.2253C>Tp.Asn751Asn
synonymous
Exon 14 of 16ENSP00000261769.4P12830-1
CDH1
ENST00000422392.6
TSL:1
c.2070C>Tp.Asn690Asn
synonymous
Exon 13 of 15ENSP00000414946.2P12830-2
CDH1
ENST00000562836.5
TSL:1
n.2324C>T
non_coding_transcript_exon
Exon 13 of 15

Frequencies

GnomAD3 genomes
AF:
0.0391
AC:
5949
AN:
152028
Hom.:
139
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0514
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0691
Gnomad ASJ
AF:
0.0153
Gnomad EAS
AF:
0.0731
Gnomad SAS
AF:
0.0410
Gnomad FIN
AF:
0.0153
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0280
Gnomad OTH
AF:
0.0326
GnomAD2 exomes
AF:
0.0429
AC:
10791
AN:
251474
AF XY:
0.0400
show subpopulations
Gnomad AFR exome
AF:
0.0544
Gnomad AMR exome
AF:
0.100
Gnomad ASJ exome
AF:
0.0121
Gnomad EAS exome
AF:
0.0765
Gnomad FIN exome
AF:
0.0181
Gnomad NFE exome
AF:
0.0259
Gnomad OTH exome
AF:
0.0373
GnomAD4 exome
AF:
0.0330
AC:
48303
AN:
1461686
Hom.:
1031
Cov.:
33
AF XY:
0.0327
AC XY:
23784
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.0547
AC:
1830
AN:
33480
American (AMR)
AF:
0.0950
AC:
4250
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0133
AC:
348
AN:
26136
East Asian (EAS)
AF:
0.0744
AC:
2954
AN:
39692
South Asian (SAS)
AF:
0.0396
AC:
3415
AN:
86242
European-Finnish (FIN)
AF:
0.0174
AC:
930
AN:
53414
Middle Eastern (MID)
AF:
0.0217
AC:
125
AN:
5768
European-Non Finnish (NFE)
AF:
0.0292
AC:
32458
AN:
1111852
Other (OTH)
AF:
0.0330
AC:
1993
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
2583
5166
7749
10332
12915
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1374
2748
4122
5496
6870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0392
AC:
5965
AN:
152146
Hom.:
142
Cov.:
32
AF XY:
0.0398
AC XY:
2959
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0514
AC:
2133
AN:
41520
American (AMR)
AF:
0.0691
AC:
1055
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
53
AN:
3470
East Asian (EAS)
AF:
0.0723
AC:
374
AN:
5172
South Asian (SAS)
AF:
0.0410
AC:
198
AN:
4824
European-Finnish (FIN)
AF:
0.0153
AC:
162
AN:
10584
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0280
AC:
1901
AN:
67990
Other (OTH)
AF:
0.0393
AC:
83
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
276
552
829
1105
1381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0356
Hom.:
39
Bravo
AF:
0.0449
Asia WGS
AF:
0.0810
AC:
279
AN:
3478
EpiCase
AF:
0.0266
EpiControl
AF:
0.0279

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
Hereditary diffuse gastric adenocarcinoma (4)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
1
CDH1-related diffuse gastric and lobular breast cancer syndrome (1)
-
-
1
Malignant tumor of breast (1)
-
-
1
Prostate cancer (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
0.56
DANN
Benign
0.82
PhyloP100
-2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33964119; hg19: chr16-68862165; COSMIC: COSV55729698; COSMIC: COSV55729698; API